What are hyperplastic thyroid nodules?

What are Hyperplastic Thyroid Nodules?

Hyperplastic thyroid nodules are benign, non-neoplastic growths that result from the proliferation of thyroid follicular epithelium in response to hormonal stimulation, representing the most common type of thyroid nodule and requiring no treatment in the vast majority of cases.

Pathophysiology and Classification

Hyperplastic nodules arise from the physiologic response of follicular epithelium to hormonal changes, particularly disturbances in the feedback mechanism involving thyrotropin-releasing hormone (TRH) and thyroid-stimulating hormone (TSH) 1. These nodules represent an amplification of normal thyroid heterogeneity through genetic and/or epigenetic mechanisms 2.

Thyrocyte proliferation in hyperplastic nodules occurs primarily through TSH receptor (TSHR), cyclic AMP (cAMP), and protein kinase A (PKA) pathways, though several paracrine and autocrine factors secreted by follicular cells, stromal apparatus, and lymphocytes also contribute to initiation and perpetuation 2.

Clinical Characteristics

Hyperplastic nodules manifest as part of the spectrum of nodular thyroid disease, commonly presenting as:

• Sporadic goiter (diffuse or nodular hyperplasia)
• Nodular hyperplasia - the most common benign thyroid nodule type, often called a "leave me alone" lesion 3
• Oncocytic nodular hyperplasia - well-defined, sharply circumscribed but unencapsulated nodules composed of oncocytic thyroid follicular cells, typically associated with chronic lymphocytic thyroiditis 4

The vast majority occur in euthyroid patients and cause neither compressive symptoms nor cosmetic concerns 5.

Ultrasound Features

Hyperplastic nodules have specific ultrasound characteristics that help distinguish them from neoplastic lesions:

• Predominantly cystic content (24.5% of cases) versus follicular adenomas which are almost exclusively solid 3
• Spongiform appearance - present exclusively in hyperplastic nodules (17% of cases) 3
• Isoechoic pattern - seen in 83% of hyperplastic nodules 3
• May appear more contrasted than adjacent parenchyma due to thickness, with normal TSH levels 6

These features are critical because they can help avoid unnecessary fine-needle aspirations for these benign "leave me alone" lesions 3.

Histologic Features and Diagnostic Pitfalls

Hyperplastic nodules can display concerning histologic features that may be mistaken for malignancy 1:

• Florid papillary hyperplasia (13% of cases) - can closely resemble papillary thyroid carcinoma
• Nuclear clearing resembling "Orphan-Annie" nuclei (15% of cases)
• Nuclear grooves and pseudonuclear inclusions (8% of cases)
• Cytologic atypia including nuclear enlargement, multinucleation, and pleomorphism (7% of cases)
• Mitoses (6% of cases, averaging 1-2 per 20 high-power fields)
• Psammoma bodies (1.3% of cases)

In pediatric patients, solitary papillary hyperplastic thyroid nodules can be particularly challenging, as fine-needle aspiration may yield findings suspicious for papillary carcinoma, including broad flat sheets, 3-dimensional clusters with "fire flares," and short nonbranching papillae 7. However, the absence of intranuclear inclusions and presence of watery/inspissated colloid help distinguish these benign lesions from true malignancy 7.

Management Approach

The cornerstone of management is recognition and conservative observation 8:

1. Initial evaluation: TSH measurement is the best initial test 8
2. Ultrasound assessment: Use standardized risk stratification systems (C-TIRADS, ACR TI-RADS) 9
3. FNA indications: Based on nodule size and ultrasound risk features, not simply presence of a nodule 8

Most patients with benign hyperplastic nodules do not require any treatment 8:

• Levothyroxine suppressive therapy is NOT recommended in euthyroid patients 8
• In iodine-deficient regions, iodine supplementation may be considered 8
• Non-TSH-suppressive LT4 treatment may be considered in young patients with small nodular goiter 8

Clinical Outcomes

Long-term follow-up studies demonstrate excellent prognosis. In oncocytic nodular hyperplasia, clinical follow-up ranging from 7 to 22 years showed no evidence of recurrence, metastasis, or malignant transformation 4. This underscores that hyperplastic nodules are truly benign processes requiring recognition rather than aggressive intervention.

Key Clinical Pearls

• Hyperplastic nodules should not be confused with "hyperplastic" appearance on scintigraphy, which may simply reflect nodule thickness rather than true autonomy 6
• The presence of hyperplastic features on histology does not indicate malignant potential
• Awareness of the histologic mimics of malignancy is essential to avoid overtreatment 1
• The primary clinical challenge is distinguishing these benign lesions from the 5% of thyroid nodules that are truly malignant 10, while avoiding the substantial burden of unnecessary evaluation and treatment 11